GlassScriptPhysician profile
Anna-Marie Tharp
NPI 1851780449
$915.88
in general payments reported to CMS, 2019-2025
11 companies · $132 in 2025
The $132 reported for 2025 was more than what 81% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
See the full distribution for Nurse Anesthetist, Certified Registered
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.56 · 2022: $52.37 · 2023: $340 · 2024: $378 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $848.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $230.60 | 2021-2025 | Entyvio, Gattex |
| Intercept Pharmaceuticals, INC. | $221.17 | 2022-2024 | Ocaliva |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $108.27 | 2023-2024 | Xifaxan, Plenvu |
| Boston Scientific Corporation | $76.78 | 2023-2025 | Varithena Administration Pack |
| Janssen Biotech, INC. | $65.33 | 2024-2025 | Stelara, Tremfya |
| Regeneron Healthcare Solutions, INC. | $58.52 | 2023-2024 | Dupixent |
| Lilly USA, LLC | $43.95 | 2024-2025 | Omvoh, Zepbound |
| Edwards Lifesciences Corporation | $42.02 | 2023 | Hemosphere |
| Becton, Dickinson and Company | $37.54 | 2025 | Hemosphere |
| Merck Sharp & Dohme LLC | $17.87 | 2023 | Dificid |
| Braintree Laboratories, INC. | $13.83 | 2024 | Suflave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna-Marie Tharp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.